Search Results - "Mach, F"

Reduction of Optimization Problem by Combination of Optimization Algorithm and Sensitivity Analysis by Mach, F.

“…An optimization technique based on the combination of optimization algorithm and sensitivity analysis is discussed. The technique allows reducing the number of…”
Get full text

Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis by Montecucco, F., Mach, F.

“…RA is characterized by a systemic inflammatory state, in which immune cells and soluble mediators play a crucial role. These inflammatory processes resemble…”
Get full text

Pathophysiological role of neutrophils in acute myocardial infarction by Carbone, F, Nencioni, A, Mach, F, Vuilleumier, N, Montecucco, F

“…The pathogenesis of acute myocardial infarction is known to be mediated by systemic, intraplaque and myocardial inflammatory processes. Among different immune…”
Get more information

The Role of the Endocannabinoid System in Atherosclerosis by Mach, F., Steffens, S.

“…Our current understanding of the pathophysiology of atherosclerosis suggests a prominent role for immune responses from its initiation through its…”
Get full text

Autoantibodies to C-terminal apolipoprotein a-1 as independent predictors of graft failure in renal transplant recipients by Vuilleumier, N., Anderson, J., Pagano, S., Virzi, J., Annema, W., Hartley, O., Mach, F., Bakker, S., Tietge, U.

Get full text

Statins inhibit C-reactive protein-induced chemokine secretion, ICAM-1 upregulation and chemotaxis in adherent human monocytes by Montecucco, F., Burger, F., Pelli, G., Poku, N. K., Berlier, C., Steffens, S., Mach, F.

“…Objectives. We have recently shown that CRP induces chemokine secretion and adhesion molecule up-regulation in human primary monocytes cultured in adherence…”
Get full text

Cannabinoid receptors in acute and chronic complications of atherosclerosis by Mach, F, Montecucco, F, Steffens, S

“…Atherosclerosis is a chronic inflammatory disease that is the primary cause of myocardial infarction and stroke, which occur after sudden thrombotic occlusion…”
Get full text

Leukocyte recruitment in atherosclerosis: potential targets for therapeutic approaches? by Braunersreuther, V, Mach, F

“…Atherosclerosis is a complex inflammatory disease involving cellular migration and interaction. Vascular injury in response to different cardiovascular risk…”
Get full text

Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases by Carbone, F, Nencioni, A, Mach, F, Vuilleumier, N, Montecucco, F

“…Atherothrombosis is the major determinant of acute ischaemic cardiovascular events, such as myocardial infarction and stroke. Inflammatory processes have been…”
Get more information

Inhibition of CD40 Signaling Limits Evolution of Established Atherosclerosis in Mice by Schonbeck, U., Sukhova, G. K., Shimizu, K., Mach, F., Libby, P.

“…Interruption of inflammatory pathways may provide a novel approach to the therapy of atherosclerosis. Recently, we and others have implicated the immune…”
Get full text

Model of Induction Heating of Rotating Non-Magnetic Billets and its Experimental Verification by Mach, F., Karban, P., Dolezel, I., Sima, P., Jelinek, Z.

“…Induction heating of non-magnetic cylindrical billets is modeled. The billet rotates in static magnetic field generated by appropriately distributed permanent…”
Get full text

Clinical predictors of dual aspirin and clopidogrel poor responsiveness in stable cardiovascular patients from the ADRIE study by FONTANA, P., BERDAGUÉ, P., CASTELLI, C., NOLLI, S., BARAZER, I., FABBRO‐PERAY, P., SCHVED, J.‐F., BOUNAMEAUX, H., MACH, F., DE MOERLOOSE, P., RENY, J.‐L.

“…Background: Poor response to both aspirin and clopidogrel (dual poor responsiveness [DPR]) is a major risk factor for recurrent ischemic events. Objectives:…”
Get full text

Initial systolic blood pressure associates with systemic inflammation, myocardial injury, and outcomes in patients with acute coronary syndromes by Winzap, Patric A, Kraler, Simon, Obeid, Slayman, Wenzl, Florian A, Templin, Christian, Klingenberg, Roland, von Eckardstein, Arnold, Roffi, Marco, Muller, Olivier, Räber, Lorenz, Lüscher, Thomas F

“…Abstract Aims Outcomes after acute coronary syndromes (ACS) are determined by baseline risk profiles, including initial systolic blood pressure (sBP) levels…”
Get full text

The Stromal Cell–Derived Factor-1 Chemokine Is a Potent Platelet Agonist Highly Expressed in Atherosclerotic Plaques by Abi-Younes, S, Sauty, A, Mach, F, Sukhova, G K, Libby, P, Luster, A D

“…ABSTRACTChemokines are chemotactic cytokines that activate and direct the migration of leukocytes. However, their role in modulating platelet function has not…”
Get full text

Statins: the new aspirin? by Veillard, N R, Mach, F

“…3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, or statins, have been described as the principal and the most effective class of drug to…”
Get full text

The liver and the kidney: two critical organs influencing the atherothrombotic risk in metabolic syndrome by Carbone, F, Montecucco, F, Mach, F, Pontremoli, R, Viazzi, F

“…The increased atherothrombotic risk in patients with metabolic syndrome (MetS) has been classically explained by the multiplicative effect of systemic…”
Get more information

Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice by MERHI-SOUSSI, Faten, KWAK, Brenda R, MAGNE, David, CHADJICHRISTOS, Christos, BERTI, Marina, PELLI, Graziano, JAMES, Richard W, MACH, Francois, GABAY, Cem

“…To examine the role of the balance between interleukin (IL)-1 and IL-1 receptor antagonist (IL-1Ra) in atherosclerosis and vascular inflammation. Transgenic…”
Get full text

Update on therapeutic strategies to increase adiponectin function and secretion in metabolic syndrome by Montecucco, F., Mach, F.

“…Changes in diagnostic criteria have impacted on the definition of the metabolic syndrome. The central aetiological importance of insulin resistance has…”
Get full text

Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis by Wick, P. A., Mombelli, A., Pagano, S., Moren, X., Giannopoulou, C., Mach, F., Roux-Lombard, P., Vuilleumier, N.

“…Background and Objective Anti‐apolipoprotein A‐1 (anti‐apoA‐1) IgG is a potential marker of atherosclerotic plaque vulnerability and cardiovascular…”
Get full text

Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction by Keller, P.-F., Pagano, S., Roux-Lombard, P., Sigaud, P., Rutschmann, O. T., Mach, F., Hochstrasser, D., Vuilleumier, N.

“…  Keller P‐F, Pagano S, Roux‐Lombard P, Sigaud P, Rutschmann OT, Mach F, Hochstrasser D Vuilleumier N (Geneva University Hospitals, Geneva). Autoantibodies…”
Get full text